On 10/16/24, Voyager Therapeutics Inc (NASDAQ: VYGR) stock enjoyed a major increase of 15.5%, closing at $7.91. Moreover, this advance was accompanied by exceptionally high trading volume at 237% of normal. The stock has risen 11.7% during the last week but has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
VYGR’s future returns on capital are forecasted to fall short of the cost of capital. Accordingly, the company is expected to be a modest Value Eraser.
Voyager Therapeutics has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing complementary signals. Voyager Therapeutics has a slightly negative Appreciation Score of 35 and a very low Power Rating of 9, triggering the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment